Dr. Jeffrey Sterling

Head of CMC

CMC Leader at NeuroSense, responsible for product and formulation development.

He is an accomplished researcher with over 40  years of experience in Research and Development at Teva Pharmaceuticals. He is one of the inventors of Azilect ® (Parkinson’s).

He has received numerous prizes and achievements, including the Rothschild Prize for Innovation and Horev Prize for Excellence in Medicinal Chemistry.

Ph.D. in Chemistry, from Johns Hopkins University